New Illuma Growing-up Infant Formula Now Available throughout China
Comunicato Precedente
Comunicato Successivo
Wyeth Nutrition 's long-term dedication and solid research foundation in this area allowed them to become the first multinational company to debut this innovative product in China. Over the course of its 30-year research career, it has undertaken 55 HMO-related studies, completed over 30 clinical trials, published over 70 research papers on the subject, and been given over 100 patents connected to HMOs. With the addition of six crucial HMOs, the company's most recent infant formula product, illuma LUXA, has the highest number of HMOs of any infant formula on the market right now.
The introduction of the illuma HMO growing-up infant formula highlights Wyeth Nutrition's "in China, for China" commitment in addition to showcasing the company's overall strength. In order to expedite formula upgrading in the future, Wyeth Nutrition will continue to comprehend the wants of Chinese moms and infants while utilizing its state-of-the-art technologies and global resources. Additionally, Wyeth Nutrition will keep strengthening its local R&D, production, and supply chains in order to provide high-quality, high-standard products that satisfy the increasingly varied nutritional needs of Chinese customers.
Photo - https://mma.prnewswire.com/media/2306254/s4kv_1205final.jpg
View original content:https://www.prnewswire.co.uk/news-releases/new-illuma-growing-up-infant-formula-now-available-throughout-china-302021053.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
